Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
Titel:
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
Auteur:
Albanell, J. González, A. Ruiz-Borrego, M. Alba, E. García-Saenz, J.A. Corominas, J.M. Burgues, O. Furio, V. Rojo, A. Palacios, J. Bermejo, B. Martínez-García, M. Limon, M.L. Muñoz, A.S. Martín, M. Tusquets, I. Rojo, F. Colomer, R. Faull, I. Lluch, A.